Contribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed

British Journal of Clinical Pharmacology

Volumn 66, Issue 2, 2008, Pages 300-303

  Attinà, Teresa M ^a   Oliver, James J ^b   Malatino, Lorenzo S ^c   Webb, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Acetylcholine; Atropine; Darifenacin; Forearm blood flow; Muscarinic receptors

Indexed keywords

ACETYLCHOLINE; ATROPINE; DARIFENACIN; MUSCARINIC M3 RECEPTOR; PLACEBO; MUSCARINIC RECEPTOR; VASODILATOR AGENT;

ADULT; ARM BLOOD FLOW; ARM BLOOD VESSEL; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG RECEPTOR BINDING; FOREARM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; VASCULAR ENDOTHELIUM; VASODILATATION; XEROSTOMIA; CASE CONTROL STUDY; DRUG EFFECT; FEMALE; PATHOPHYSIOLOGY; VASCULAR RESISTANCE; VASCULARIZATION;

ACETYLCHOLINE; ADULT; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; MALE; RECEPTORS, MUSCARINIC; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 47249124063     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03194.x     Document Type: Article

References (13)

1. Eglen RM, Whiting RL. Heterogeneity of vascular muscarinic receptors. J Auton Pharmacol 1990 10 : 233 45.
2. Boulanger CM, Morrison KJ, Vanhoutte PM. Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat. Br J Pharmacol 1994 112 : 519 24.
3. Jaiswal N, Lambrecht G, Mutschler E, Tacke R, Malik KU. Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. J Pharmacol Exp Ther 1991 258 : 842 50.
4. Bruning TA, Hendriks MG, Chang PC, Kuypers EA, van Zwieten PA. In vivo characterization of vasodilating muscarinic-receptor subtypes in humans. Circ Res 1994 74 : 912 9.
5. Norel X, Walch L, Costantino M, Labat C, Gorenne I, Dulmet E, Rossi F, Brink C. M1 and M3 muscarinic receptors in human pulmonary arteries. Br J Pharmacol 1996 119 : 149 57.
6. Yamada S, Maruyama S, Takagi Y, Uchida S, Oki T. In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice. Life Sci 2006 80 : 127 32.
7. Haab F, Corcos J, Siami P, Glavind K, Dwyer P, Steel M, Kawakami F, Lheritier K, Steers WD. Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study. BJU Int 2006 98 : 1025 32.
8. Wilkinson IB, Webb DJ. Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol 2001 52 : 631 46.
9. Chapple C, Steers W, Norton P, Millard R, Kralidis G, Glavind K, Abrams P. A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder. BJU Int 2005 95 : 993 1001.
10. Kay GG, Wesnes KA. Pharmacodynamic effects of darifenacin, a muscarinic M selective receptor antagonist for the treatment of overactive bladder, in healthy volunteers. BJU Int 2005 96 : 1055 62.
11. Eglen RM, Choppin A, Watson N. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci 2001 22 : 409 14.
12. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 2006 148 : 565 78.
13. Dawes M, Chowienczyk PJ, Ritter JM. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature. Br J Pharmacol 2001 134 : 939 44.